- Home
- LRMR vs MACI Comparison
LRMR vs MACI Comparison
Compare LRMR & MACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- MACI
- Stock Information
- Founded
- LRMR N/A
- MACI 2024
- Country
- LRMR United States
- MACI United States
- Employees
- LRMR N/A
- MACI N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- MACI
- Sector
- LRMR Health Care
- MACI
- Exchange
- LRMR Nasdaq
- MACI NYSE
- Market Cap
- LRMR 204.9M
- MACI 227.5M
- IPO Year
- LRMR N/A
- MACI 2024
- Fundamental
- Price
- LRMR $3.88
- MACI $10.52
- Analyst Decision
- LRMR Strong Buy
- MACI
- Analyst Count
- LRMR 7
- MACI 0
- Target Price
- LRMR $17.86
- MACI N/A
- AVG Volume (30 Days)
- LRMR 892.3K
- MACI 34.2K
- Earning Date
- LRMR 08-06-2025
- MACI 01-01-0001
- Dividend Yield
- LRMR N/A
- MACI N/A
- EPS Growth
- LRMR N/A
- MACI N/A
- EPS
- LRMR N/A
- MACI 0.33
- Revenue
- LRMR N/A
- MACI N/A
- Revenue This Year
- LRMR N/A
- MACI N/A
- Revenue Next Year
- LRMR N/A
- MACI N/A
- P/E Ratio
- LRMR N/A
- MACI $31.95
- Revenue Growth
- LRMR N/A
- MACI N/A
- 52 Week Low
- LRMR $1.61
- MACI $9.95
- 52 Week High
- LRMR $9.88
- MACI $10.83
- Technical
- Relative Strength Index (RSI)
- LRMR 69.65
- MACI N/A
- Support Level
- LRMR $3.11
- MACI N/A
- Resistance Level
- LRMR $4.01
- MACI N/A
- Average True Range (ATR)
- LRMR 0.27
- MACI 0.00
- MACD
- LRMR 0.03
- MACI 0.00
- Stochastic Oscillator
- LRMR 85.64
- MACI 0.00
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.